Medical Device Network on MSN
Inside medtech’s dark factory shift: new issue of Medical Technology out now
In this issue: the rise of dark factories in medtech manufacturing, hospital cybersecurity, the sterile processing evolution, and more ...
Sequel Med Tech has a plan to explore a new type of ultra-concentrated and fast-acting insulin, to see how it may work with its automated pump and potentially offer a longer-lasting system for people ...
Medical professionals don’t pursue careers in healthcare out of a love of data entry, but it’s an inescapable daily reality for most, taking time away from focused care and consultations with patients ...
Investor's Business Daily on MSN
This medical technology specialist needs a push to break out
This medical technology developer specializes in preserving organs for transplant. Its stock is in a cup-with-handle base.
Researchers at The Hong Kong University of Science and Technology (HKUST) have developed a groundbreaking AI technology that reconstructs precise 3D bones and organs models from minimal X-ray images, ...
Sequel Med Tech and Senseonics have announced a collaboration to integrate Sequel’s twiist Automated Insulin Delivery (AID) System with Senseonics’ Eversense 365 one-year Continuous Glucose Monitoring ...
How a one-minute dental treatment became a big opportunity.
Technological advances are transforming medicine, but it may be making your physician less creative. Are technological advances making doctors lose the art of medicine? Of the many patients waiting to ...
CELZ-201-DDT is a proprietary allogeneic regenerative therapy designed to target the underlying pathology of DDD. Administered via ultrasound-guided injection, it offers a minimally invasive, ...
Medical technology has experienced unprecedented growth and development over the past few decades, resulting in significant advancements that have transformed the landscape of patient care.
It has been a tough few years for European med-tech companies but the tide seems to be turning in 2025. BioWorld garnered the views of leading investors and several companies on the coming year.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果